Prostate cancer
Choose a type
On this page
-
What is prostate cancer?
-
Symptoms of prostate cancer
-
Risk factors of prostate cancer
-
Diagnosis of prostate cancer
-
Staging and grading of prostate cancer
-
Treatment of prostate cancer
-
After prostate cancer treatment
-
Get this information in another language or format
-
About our information
-
How we can help
What is prostate cancer?
Prostate cancer is the most common cancer in men in the UK. About 55,100 people are diagnosed with it each year. It is more common over the age of 65. It can happen at a younger age, but it is uncommon under the age of 50. There is a higher risk of getting prostate cancer at a younger age if you are Black or have a strong family history of prostate cancer.
Prostate cancer starts in the cells of the prostate. The prostate is a small gland that is just below the bladder and in front of the rectum (back passage).
There are different types of prostate cancer:
- Early (localised) prostate cancer – the cancer cells are only inside the prostate
- Locally advanced prostate cancer – the cancer has grown through the capsule surrounding the prostate. It may have started to spread into tissue or organs close by.
- Advanced prostate cancer – the cancer cells have spread from the prostate gland and nearby area to other parts of the body.
If you are a trans (transgender) woman or are non-binary assigned male at birth, you still need to be aware of prostate cancer. Trans women can develop prostate cancer, but there is not enough evidence to know how common this is.
This video explains prostate cancer. Consultant urologist Jonathan Aning talks abut what it is, the different types and the treatments that may be offered to you.
Related pages
Booklets and resources
Symptoms of prostate cancer
Prostate cancer often grows slowly. Symptoms may not develop for many years. Symptoms usually happen when the cancer is large enough to press on the tube you pee (pass urine) through. This is called the urethra.
The prostate can also become enlarged due to a condition called benign prostatic hyperplasia (BPH). Benign means non-cancerous. BPH can develop as you get older.
The symptoms of benign prostate conditions and prostate cancer are similar. Some people will have both BPH and prostate cancer. If you have any of these symptoms, it is important to have them checked by your GP:
- needing to pee more often than usual, especially at night
- difficulty peeing – for example, a weak flow or having to strain to start peeing
- feeling like you have not completely emptied your bladder
- an urgent need to pee
- blood in your urine
- blood in your semen
- pain when peeing or ejaculating – this is rare.
Sometimes blood in the urine cannot be seen. It can only be detected by a urine test.
Sometimes prostate cancer can cause other symptoms, such as problems getting or keeping an erection (erectile dysfunction). It can also cause loss of appetite and weight loss.
When prostate cancer spreads, it usually goes to the bones. This is called advanced (metastatic) prostate cancer It may cause pain in the bones, such as in the back.
It is important to tell your GP if you have any of these symptoms.
Related pages
Risk factors of prostate cancer
Doctors do not know the exact causes of prostate cancer. But there are risk factors that can increase your chance of developing it. If you are Black, you have a much higher risk of developing prostate cancer. You are also more likely to develop it at a younger age. Having a strong family history of prostate cancer is also a risk factor.
We have more information about the causes and risk factors of prostate cancer.
Diagnosis of prostate cancer
If you have symptoms, you will usually begin by seeing your GP, who will examine you. They may do the following tests:
-
Digital rectal examination (DRE)
During a digital rectal examination (DRE), the doctor lubricates a gloved finger with gel. Then they gently insert it through the anus and into the rectum to feel the prostate. As the rectum sits behind the prostate, your doctor can feel for any abnormalities. DRE can detect other conditions, such as inflammation of the prostate (prostatitis) and BPH, as well as a possible prostate cancer.
DRE may feel uncomfortable, but it is quick and should not be painful. Tell the doctor or nurse if you feel pain.
If you are worried or feel uncomfortable about having a DRE, tell your GP or urologist. There are other tests for prostate cancer so they may decide not to do a DRE if you feel this way. -
PSA test
The PSA test is a blood test. It can be used with other tests to help diagnose prostate cancer.
Prostate-specific antigen (PSA) is a protein made in the prostate. Some PSA leaks into the blood and can be measured in the PSA test.
Prostate cancer often causes a raised level of PSA. But the test is not always reliable. A raised level of PSA does not mean you have prostate cancer.
Naturally, as you get older, the level of PSA in the blood slowly rises. Your doctor can tell you what they think the normal level of PSA should be for you.
If they think that your symptoms could be caused by cancer, they will refer you to a specialist doctor.
At the hospital
A specialist doctor or nurse asks about your symptoms and any other medical conditions. They check if you have any risk factors for prostate cancer. The doctor may do another rectal examination and arrange another PSA test. They will talk to you about further tests you may have. These may include:
-
A multi-parametric MRI scan
You may have this specialised scan to help your doctor decide if you need to have a prostate biopsy. A multi-parametric MRI scan gives a more detailed picture of the prostate gland and surrounding area than a standard MRI scan.
-
Trans-rectal ultrasound (TRUS) biopsy
You may have a TRUS biopsy if tests show you may have prostate cancer. They use a fine needle to remove samples of prostate tissue to examine for cancer cells. This is done through an ultrasound probe your doctor passes into your back passage. You have an injection of local anaesthetic to numb the area first.
-
Trans-Perineal (TP) biopsy
You may have a Trans-Perineal biopsy instead of a TRUS biopsy. The doctor takes samples of the prostate gland through the area between the scrotum and the back passage (called the perineum). It can be done under a general anaesthetic or using local anaesthetic to numb the area first.
Further tests after diagnosis
Your specialist may arrange further tests to find out more about the cancer or to check whether it has spread:
-
MRI scan
An MRI scan can show if the cancer has spread outside the prostate to areas nearby. The procedure is the same as for a multi-parametric multi-parametric MRI (mpMRI) scan.
-
CT scan
A CT scan makes a 3D picture of the inside of the body using x-rays taken by the CT scanner. You may have a CT scan if you are unable to have an MRI due to the magnet.
-
Bone scan
The bones are the most common place for prostate cancer to spread to beyond the lymph nodes. A bone scan can show abnormal areas of bone.
Waiting for test results can be a difficult time. We have more information that can help.
Related pages
Booklets and resources
Staging and grading of prostate cancer
Knowing the stage, grade and risk group of the cancer helps you and your doctor to decide on the best treatment for you.
The stage
The stage of prostate cancer describes its size and how far it has spread, based on your test results. Doctors often use the TNM staging system or a number staging system.
The grade
Your doctor decides the grade by how the prostate cancer cells (from your biopsy) look under the microscope. This tells them how quickly the cancer might grow or spread. Doctors use a combination of 2 systems to grade prostate cancer:
- Gleason score - examines the pattern of cells in the prostate tissues and grades them from 1 to 5. The most common and highest grades are added to give your Gleason score
- Grade Group - grades the cancer between 1 and 5 based on your Gleason score.
Risk group
Prostate cancer is also divided into risk groups. Your treatment options will depend on the risk group the cancer is in.
Your doctor looks at the stage of the cancer, your PSA level and your Gleason score to work out the risk group. They use a system called the Cambridge Prognostic Group (CPG). It divides prostate cancer risk into 5 different groups.
Treatment of prostate cancer
A team of specialists meet to discuss the best possible treatment for you. This is called a multidisciplinary team (MDT). There are different treatments. Your treatment will depend on:
- your general health
- your age
- the Gleason score, cancer grade
- the stage of the cancer
- the risk group of the cancer
- your preferences.
Your doctor and nurse will talk to you about the different things to think about when making treatment decisions. They will explain the different benefits and disadvantages of each treatment. You and your doctor can then decide on the best treatment for you.
Treatment for early or locally advanced prostate cancer may include one or more of the following:
-
Radiotherapy
Radiotherapy uses high energy rays to destroy cancer cells. It can be given from outside the body (external beam radiotherapy) and also from inside the body (brachytherapy). In early prostate cancer sometimes brachytherapy is given as the only treatment.
If you have locally advanced prostate cancer you usually have a combination of external radiotherapy and brachytherapy.
-
Surgery or radical prostatectomy
Surgery to remove the prostate gland is called a prostatectomy. If you have early prostate cancer you may be asked to decide between having a prostatectomy and radiotherapy. Prostatectomy is not often done in locally advanced prostate cancer.
-
Monitoring
- Active surveillance
Active surveillance involves having regular tests to monitor early prostate cancer. It can help to avoid unnecessary treatment or to delay treatment and its side effects. - Watchful waiting
During watchful waiting, you will not have as many tests as with active surveillance. You see your doctor regularly to check if the cancer is causing symptoms. If you have symptoms or there are signs the cancer is growing you can have treatment, usually with hormonal therapy.
Find out more about monitoring prostate cancer.
- Active surveillance
-
Hormonal therapy
Prostate cancer needs the hormone testosterone to grow. Hormonal therapies reduce the amount of testosterone in the body. You may have hormonal therapy as tablets or injections. It may be given with radiotherapy and for some time afterwards. Hormonal therapy is sometimes given on its own.
-
Chemotherapy
Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells.
Chemotherapy is sometimes used for locally advanced prostate cancer that has a higher risk of coming back. It is more commonly used to treat advanced prostate cancer.
-
Other treatments
Other treatments may sometimes be used to treat early prostate cancer. Cryotherapy uses cold to freeze and destroy prostate cancer cells. HIFU uses heat delivered through an ultrasound to destroy prostate cancer cells. These treatments may not be widely available on the NHS.
Advanced (metastatic) prostate cancer is usually treated with hormonal therapy and chemotherapy.
We have more information about prostate cancer treatments, including treatment options for early prostate cancer and locally advanced prostate cancer.
After prostate cancer treatment
You will have regular follow-up appointments after treatment for prostate cancer.
You may get anxious between appointments. This is natural. It may help to get support from family, friends or a support organisation such as Prostate Cancer UK.
Macmillan is also here to support you. If you would like to talk, you can:
- Call the Macmillan Support Line for free on 0808 808 00 00.
- Chat to our specialists online.
- Visit our prostate cancer forum to connect with people who have been affected by prostate cancer, share your experience, and ask your questions.
Sex, relationships and fertility
Prostate cancer treatments can affect your sex life. They can reduce your sex drive (libido) and cause difficulties getting an erection. This is called erectile dysfunction or ED. This may be very worrying for you. There are different treatments and support available to improve sexual difficulties.
Talk to your doctor or nurse about sexual difficulties or concerns. They will be used to talking about these issues. You may want to involve a partner in these discussions.
Fertility
Prostate cancer treatments can affect your fertility. If this is a concern for you, talk to your doctor or nurse. You may be able to store sperm before treatment starts.
Well-being and recovery
Even if you already have a healthy lifestyle, you may choose to make some positive lifestyle changes after treatment.
Small changes to the way you live such as eating well and keeping active can improve your health and well-being and help your body recover.
Get this information in another language or format
We are committed to making our website as accessible as possible, to make sure that everyone can use it.
We have information about prostate cancer in over 16 languages, and in other formats including audiobooks, and easy read.
If we don't have what you are looking for, you can ask for information to be translated for free or provided in a format to suit you. Email us at cancerinformationteam@macmillan.org.uk or call us on 0808 808 00 00.
About our information
-
References
Below is a sample of the sources used in our prostate cancer information. If you would like more information about the sources we use, please contact us at cancerinformationteam@macmillan.org.uk
C. Parker, E. Castro, K. Fizazi, et al. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 2020, Volume 31, Issue 9, p1119-1134. Available from https://www.esmo.org/guidelines/esmo-clinical-practice-guideline-prostate-cancer
National Institute for Health and Care Excellence (2019) Prostate cancer: diagnosis and management (NICE guideline NG131). Last updated December 2021 to include Risk stratification for localised or locally advanced prostate cancer. Available at www.nice.org.uk/guidance/ng131
-
Reviewers
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editors, Dr Jim Barber, Consultant Clinical Oncologist and Dr Ursula McGovern, Consultant Medical Oncologist.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.
The language we use
We want everyone affected by cancer to feel our information is written for them.
We want our information to be as clear as possible. To do this, we try to:
- use plain English
- explain medical words
- use short sentences
- use illustrations to explain text
- structure the information clearly
- make sure important points are clear.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected.
You can read more about how we produce our information here.
Date reviewed
This content is currently being reviewed. New information will be coming soon.

Our cancer information meets the PIF TICK quality mark.
This means it is easy to use, up-to-date and based on the latest evidence. Learn more about how we produce our information.
